Medical Research Council (MRC) Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 0XZ, United Kingdom.
J Biol Chem. 2010 Jun 25;285(26):20080-7. doi: 10.1074/jbc.M109.088922. Epub 2010 Apr 8.
Carriers of germ line mutations in breast cancer susceptibility gene BRCA1 have an increased risk of developing breast and ovarian cancers; missense mutations have, however, been difficult to assess for disease association. Here we have used a biophysical approach to classify these variants. We established an assay for measuring the thermodynamic stability of the BRCA1 BRCT domains and investigated the effects of 36 missense mutations. The mutations show a range of effects. Some do not change the stability, whereas others destabilize the protein by as much as 6 kcal mol(-1); one-third of the mutants could not be expressed in soluble form in Escherichia coli, and we conclude that these destabilize the protein by an even greater amount. We tested several computer algorithms for their ability to predict the mutant effects and found that by grouping them into two classes (destabilizing by less than or more than 2.2 kcal mol(-1)), the algorithms could predict the stability changes. Importantly, with the exception of the few mutants located in the binding site, none showed a significant reduction in affinity for phosphorylated substrate. These results indicate that despite very large losses in stability, the integrity of the structure is not compromised by the mutations. Thus, the majority of mutations cause loss of function by reducing the proportion of BRCA1 molecules that are in the folded state and increasing the proportion of molecules that are unfolded. Consequently, small molecule stabilization of the structure could be a generally applicable preventative therapeutic strategy for rescuing many BRCA1 mutations.
携带有乳腺癌易感基因 BRCA1 种系突变的携带者患乳腺癌和卵巢癌的风险增加;然而,错义突变的疾病相关性评估一直存在困难。在这里,我们使用了一种生物物理方法对这些变体进行分类。我们建立了一种测量 BRCA1 BRCT 结构域热力学稳定性的测定法,并研究了 36 种错义突变的影响。这些突变显示出不同的影响。有些不会改变稳定性,而其他突变则使蛋白质的稳定性降低多达 6 kcal/mol;三分之一的突变体不能在大肠杆菌中以可溶性形式表达,我们推断这些突变体使蛋白质的稳定性降低更多。我们测试了几种计算机算法来预测突变体的影响,发现通过将它们分为两类(稳定性降低小于或大于 2.2 kcal/mol),这些算法可以预测稳定性变化。重要的是,除了少数位于结合位点的突变体外,没有一个表现出对磷酸化底物亲和力的显著降低。这些结果表明,尽管稳定性有很大损失,但结构的完整性并没有因突变而受损。因此,大多数突变通过降低折叠状态的 BRCA1 分子比例和增加未折叠分子比例来导致功能丧失。因此,小分子稳定结构可能是一种普遍适用的预防治疗策略,可以挽救许多 BRCA1 突变。